CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+AML and act synergistically with the FLT3-inhibitor crenolanib

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+AML and act synergistically with the FLT3-inhibitor crenolanibCAR T-cells targeting FLT3 have potent activity against FLT3<sup>−</sup>ITD+AML and act synergistically with the FLT3-inhibitor crenolanib, Published online: 05 February 2018; doi:10.1038/s41375-018-0009-0CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+AML and act synergistically with the FLT3-inhibitor crenolanib
Source: Leukemia - Category: Hematology Authors: Source Type: research
More News: Hematology | Leukemia